Concurrent use of efavirenz and oxcarbazepine may not affect efavirenz plasma concentrations.
Goicoechea
Miguel
M
Best
Brookie
B
Capparelli
Edmund
E
Haubrich
Richard
R
D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000097:blood / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D048588:Benzoxazines; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy; D002220:Carbamazepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003521:Cyclopropanes; D003577:Cytochrome P-450 Enzyme System; D004347:Drug Interactions; D016903:Drug Monitoring; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000150:complications / Q000188:drug therapy; D009422:Nervous System Diseases / Q000150:complications / Q000188:drug therapy; D010078:Oxazines / Q000097:blood / Q000627:therapeutic use*; D000078330:Oxcarbazepine; D017211:Treatment Failure; D019562:Viral Load
D000480:Alkynes; D019380:Anti-HIV Agents; D000927:Anticonvulsants; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D002220:Carbamazepine; D003577:Cytochrome P-450 Enzyme System; C098320:efavirenz; D000078330:Oxcarbazepine